Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 3 × Constipation × tegaserod × Clear all

Phase

Phase 3 2 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Conditions

Opioid-Induced Constipation 2 Constipation 2

Interventions

alvimopan 3 tegaserod 2 oxycodone naloxone combination 1 Naloxone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00399659 2012-05-01

Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain.

Novartis

Phase 3 Terminated

Opioid-Induced Constipation, Constipation

NCT00414024 2012-04-20

Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain.

Novartis

Phase 3 Terminated

Opioid-Induced Constipation, Constipation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡